Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
leukemia
|
144 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 0 | |||||||||
Leukemia, Myelocytic, Acute
|
6892 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 7 | 1987 | 2016 | ||||||
melanoma
|
515 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.720 | 1.000 | 10 | 1989 | 2016 | ||||||
Adult Diffuse Large B-Cell Lymphoma
|
46 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
B-CELL MALIGNANCY, LOW-GRADE
|
19 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Chronic Lymphocytic Leukemia
|
291 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Diffuse Large B-Cell Lymphoma
|
127 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
Juvenile Myelomonocytic Leukemia
|
70 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.710 | 1.000 | 6 | 2000 | 2012 | ||||||
Noonan Syndrome
|
187 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 5 | 2000 | 2010 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 4 | 2002 | 2013 | ||||||
Colorectal Neoplasms
|
609 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 9 | 2006 | 2016 | ||||||
Neoplasms
|
1644 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.040 | 1.000 | 4 | 2011 | 2018 | ||||||
Malignant Neoplasms
|
1641 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2020 | ||||||
Myeloid Leukemia, Chronic
|
115 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 2 | 2012 | 2014 | ||||||
Primary malignant neoplasm
|
1374 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2020 | ||||||
Carcinoma of lung
|
1204 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Cutaneous Melanoma
|
248 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Gastric Adenocarcinoma
|
235 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Multiple Myeloma
|
865 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Sebaceous adenoma
|
6 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Brain Neoplasms
|
204 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Secondary malignant neoplasm of liver
|
34 | 0.683 | 0.440 | 1 | 114716127 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 |